Menu
Search
|

Menu

Close
X

Merck & Co Inc MRK.N (New York Stock Exchange)

54.57 USD
+0.02 (+0.04%)
As of 2:30 AM IST
chart
Previous Close 54.55
Open 54.65
Volume 2,282,508
3m Avg Volume 3,989,629
Today’s High 55.06
Today’s Low 54.42
52 Week High 66.80
52 Week Low 53.36
Shares Outstanding (mil) 2,727.35
Market Capitalization (mil) 176,050.70
Forward P/E 35.16
Dividend (Yield %) 0.47 ( 2.91 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.09 Mean rating from 22 analysts

KEY STATS

Revenue (mm, USD)
FY17
40,122
FY16
39,807
FY15
39,498
EPS (USD)
FY17
1.884
FY16
1.403
FY15
1.566
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
35.16
32.90
Price to Sales (TTM)
vs sector
4.40
5.77
Price to Book (MRQ)
vs sector
4.46
5.41
Price to Cash Flow (TTM)
vs sector
17.98
23.42
Total Debt to Equity (MRQ)
vs sector
63.06
16.52
LT Debt to Equity (MRQ)
vs sector
55.00
12.22
Return on Investment (TTM)
vs sector
6.58
14.43
Return on Equity (TTM)
vs sector
12.28
16.13

EXECUTIVE LEADERSHIP

Kenneth Frazier
Chairman of the Board, President, Chief Executive Officer, Since 2011
Salary: $1,527,400.00
Bonus: $2,518,420.00
Robert Davis
Chief Financial Officer, Executive Vice President, Since 2014
Salary: $991,654.00
Bonus: $1,092,000.00
Michael Holston
Executive Vice President, General Counsel, Since 2015
Salary: $761,538.00
Bonus: $803,985.00
Mirian Graddick-Weir
Executive Vice President - Human Resources, Since 2009
Salary: --
Bonus: --
Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

2000 Galloping Hill Rd
KENILWORTH   NJ   07033-1310

Phone: +1908.7404000

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

SPONSORED STORIES